Evidence map›Paper›PMID 31873175›Full record

ArticleScientific reports2019

Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle.

Mery Giantin, Minna Rahnasto-Rilla, Roberta Tolosi, Lorena Lucatello, Marianna Pauletto, Giorgia Guerra, Francesca Pezzato, Rosa M Lopparelli, Roberta Merlanti, Paolo Carnier and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Hypermethylation-Mediated Silencing ofInternational journal of molecular sciences · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Mery GiantinDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.ORCID http://orcid.org/0000-0003-0015-3800
Minna Rahnasto-RillaFaculty of Health Sciences, School of Pharmacy, University of Eastern Finland and Biocenter Kuopio, Kuopio, Finland.
Roberta TolosiDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Lorena LucatelloDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Marianna PaulettoDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.ORCID http://orcid.org/0000-0002-2424-7484
Giorgia GuerraDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Francesca PezzatoDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Rosa M LopparelliDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Roberta MerlantiDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Paolo CarnierDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Francesca CapolongoDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy.
Paavo HonkakoskiFaculty of Health Sciences, School of Pharmacy, University of Eastern Finland and Biocenter Kuopio, Kuopio, Finland.ORCID http://orcid.org/0000-0002-4332-3577
Mauro DacastoDepartment of Comparative Biomedicine and Food Science, Division of Pharmacology and Toxicology, University of Padua, Padua, Italy. mauro.dacasto@unipd.it.
University of Padua · ITUniversity of Eastern Finland · FIUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytochrome P450 3A is the most important CYP subfamily in humans, and CYP3A4/CYP3A5 genetic variants contribute to inter-individual variability in drug metabolism. However, no information is available for bovine CYP3A (bCYP3A). Here we described bCYP3A missense single nucleotide variants (SNVs) and evaluated their functional effects. CYP3A28, CYP3A38 and CYP3A48 missense SNVs were identified in 300 bulls of Piedmontese breed through targeted sequencing. Wild-type and mutant bCYP3A cDNAs were cloned and expressed in V79 cells. CYP3A-dependent oxidative metabolism of testosterone (TST) and nifedipine (NIF) was assessed by LC-MS/MS. Finally, SNVs functional impact on TST hydroxylation was measured ex vivo in liver microsomes from individually genotyped animals. Thirteen missense SNVs were identified and validated. Five variants showed differences in CYP3A catalytic activity: three CYP3A28 SNVs reduced TST 6β-hydroxylation; one CYP3A38 variant increased TST 16β-hydroxylation, while a CYP3A48 SNV showed enhanced NIF oxidation. Individuals homozygous for rs384467435 SNV showed a reduced TST 6β-hydroxylation. Molecular modelling showed that most of SNVs were distal to CYP3A active site, suggesting indirect effects on the catalytic activity. Collectively, these findings demonstrate the importance of pharmacogenetics studies in veterinary species and suggest bCYP3A genotype variation might affect the fate of xenobiotics in food-producing species such as cattle.

Indexed as

Mutation, MissensePolymorphism, Single NucleotideAnimalsCatalytic DomainCattleCell LineCricetulusCytochrome P-450 CYP3AGene FrequencyMaleMicrosomes, LiverModels, MolecularMolecular Docking SimulationMultigene FamilyNifedipineRecombinant ProteinsCytochrome P-450 CYP3ANifedipineRecombinant ProteinsTestosterone

Identifiers

PMID31873175
PMCPMC6927969
OpenAlexW2995895421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.